DR. JONATHAN CHRISTOPHER BENDER M.D. NPI 1649228651

NPI Details

DR. Jonathan Christopher Bender, M.D. is a hematology and oncology internal medicine in Fayetteville, GA with 30 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Jonathan Christopher Bender, M.D. NPI is 1649228651. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: OHIO MEDICAL UNIVERSITY
Graduation Year:1995

The provider's business location address is:

1265 HIGHWAY 54 W STE 4200
FAYETTEVILLE, GA
ZIP 30214
Phone: (678) 829-1060
Fax: (678) 829-1099

The NPI 1649228651 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, ferric derisomaltose, 10 mg (HCPCS:J1437)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Unclassified drugs (HCPCS:J3490)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Urinalysis, manual test (HCPCS:81002)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Administration of influenza virus vaccine (HCPCS:G0008)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Injection of drug or substance into vein (HCPCS:96374)

The enumeration date for this NPI number is 5/4/2006 and was last updated on 7/2/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: